- Home
- Publications
- Publication Search
- Publication Details
Title
Timing use of novel anti-epileptic drugs: is earlier better?
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2019-07-01
DOI
10.1080/14737175.2019.1636649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
- (2019) Iván Sánchez Fernández et al. NEUROLOGY
- Brivaracetam efficacy and safety in focal epilepsy
- (2019) Yamane Makke et al. Expert Review of Neurotherapeutics
- Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine
- (2018) Ladislav Pazdera et al. EPILEPSIA
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study
- (2018) Eugen Trinka et al. EPILEPSIA
- Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study
- (2018) Claudio Liguori et al. EPILEPSY & BEHAVIOR
- Cost-effectiveness of perampanel for the treatment of primary generalized tonic-clonic seizures (PGTCS) in epilepsy: A Spanish perspective
- (2018) Gabriel Tremblay et al. EPILEPSY & BEHAVIOR
- Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events
- (2018) Virupakshi Jalihal et al. EPILEPSY & BEHAVIOR
- Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures
- (2018) Jesus E. Piña-Garza et al. EPILEPSY & BEHAVIOR
- Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy
- (2018) Zhu Li-na et al. EPILEPSY RESEARCH
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy
- (2018) Philip N. Patsalos et al. THERAPEUTIC DRUG MONITORING
- Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis
- (2018) Martin Hirsch et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Pharmacokinetic Considerations with the Use of Antiepileptic Drugs in Patients with HIV and Organ Transplants
- (2018) Jorge J. Asconapé Current Neurology and Neuroscience Reports
- Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures
- (2018) Stefano de Biase et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
- (2018) Alessandro Galgani et al. Frontiers in Neurology
- Lacosamide versus phenytoin for the prevention of early post traumatic seizures
- (2018) Samuel J. Kwon et al. JOURNAL OF CRITICAL CARE
- Randomized controlled trials in status epilepticus: Size matters
- (2017) Francesco Brigo et al. EPILEPSIA
- Lacosamide in status epilepticus: Systematic review of current evidence
- (2017) Adam Strzelczyk et al. EPILEPSIA
- Perampanel in 12 patients with Unverricht-Lundborg disease
- (2017) Arielle Crespel et al. EPILEPSIA
- Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression
- (2017) Steve Chung et al. EPILEPSY & BEHAVIOR
- Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study
- (2017) Usha K. Misra et al. EPILEPSY & BEHAVIOR
- Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures
- (2017) Stefano de Biase et al. Expert Opinion on Drug Metabolism & Toxicology
- Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
- (2017) Michel Baulac et al. LANCET NEUROLOGY
- Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
- (2017) Miguel J. Franquiz et al. PHARMACOTHERAPY
- Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison
- (2017) Li-na Zhu et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- New developments in the management of partial-onset epilepsy: role of brivaracetam
- (2017) Giangennaro Coppola et al. Drug Design Development and Therapy
- Transition from oxcarbazepine to eslicarbazepine acetate: A single center study
- (2017) Jussi Mäkinen et al. Brain and Behavior
- A resurging boom in new drugs for epilepsy and brain disorders
- (2017) Iyan Younus et al. Expert Review of Clinical Pharmacology
- Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy
- (2016) M. Baulac et al. ACTA NEUROLOGICA SCANDINAVICA
- Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials
- (2016) Oneeb Majid et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy
- (2016) Pavel Klein et al. EPILEPSIA
- Efficacy and tolerability of perampanel in ten patients with Lafora disease
- (2016) Danielle Goldsmith et al. EPILEPSY & BEHAVIOR
- A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy
- (2016) Francesco Brigo et al. EPILEPSY RESEARCH
- New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel
- (2016) Leslie A Rudzinski et al. JOURNAL OF INVESTIGATIVE MEDICINE
- The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill
- (2016) C. R. Newey et al. Neurocritical Care
- Prevalence and incidence of epilepsy
- (2016) Kirsten M. Fiest et al. NEUROLOGY
- Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison
- (2016) Lin Zhang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs
- (2016) Francesco Brigo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Cardiac safety of lacosamide: the non-clinical perspective
- (2015) A. Delaunois et al. ACTA NEUROLOGICA SCANDINAVICA
- Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures
- (2015) G. D. Rudd et al. ACTA NEUROLOGICA SCANDINAVICA
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Lacosamide
- (2015) Willi Cawello CLINICAL PHARMACOKINETICS
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Brivaracetam and carbamazepine interaction in healthy subjects and in vitro
- (2015) Armel Stockis et al. EPILEPSY RESEARCH
- Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation
- (2015) Andreas Schulze-Bonhage Expert Opinion on Drug Metabolism & Toxicology
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide
- (2015) Simon Hebeisen et al. NEUROPHARMACOLOGY
- Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study
- (2015) Qing-Yi Zeng et al. PLoS One
- Medical management of refractory epilepsy-Practical treatment with novel antiepileptic drugs
- (2014) Elinor Ben-Menachem EPILEPSIA
- The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist
- (2014) Philip N. Patsalos EPILEPSIA
- Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
- (2014) V. Villanueva et al. EPILEPSY RESEARCH
- Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
- (2014) Jarogniew J. Łuszczki Pharmacological Reports
- Economic Evaluation of Lacosamide in the Management of Epileptic Partial Onset Seizures in Greece
- (2014) M. Geitona et al. VALUE IN HEALTH
- Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus
- (2013) C. Kellinghaus et al. ACTA NEUROLOGICA SCANDINAVICA
- Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs
- (2013) Philip N. Patsalos CLINICAL PHARMACOKINETICS
- The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis
- (2013) Nasreen Khan et al. CURRENT MEDICAL RESEARCH AND OPINION
- Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine
- (2013) Gaetano Zaccara et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Side-effects of antiepileptic drugs: The economic burden
- (2013) Reina J.A. de Kinderen et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Lacosamide Therapeutic Monitoring in Patients With Epilepsy
- (2013) Manuela Contin et al. THERAPEUTIC DRUG MONITORING
- Cost Effectiveness of Lacosamide in the Adjunctive Treatment of Patients with Refractory Focal Epilepsy in Belgium
- (2012) Steven Simoens et al. CNS DRUGS
- Antiepileptic drug monotherapy versus polytherapy
- (2012) Linda J. Stephen et al. CURRENT OPINION IN NEUROLOGY
- Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures
- (2012) Nathan B. Fountain et al. EPILEPSIA
- Pharmacokinetics and drug interactions of eslicarbazepine acetate
- (2012) Meir Bialer et al. EPILEPSIA
- Patterns of treatment response in newly diagnosed epilepsy
- (2012) M. J. Brodie et al. NEUROLOGY
- Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy
- (2012) G. L. Birbeck et al. NEUROLOGY
- Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta-analysis
- (2011) João Costa et al. EPILEPSIA
- Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial
- (2009) Péter Halász et al. EPILEPSIA
- Key factors in the discovery and development of new antiepileptic drugs
- (2009) Meir Bialer et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now